Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
28M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
552K
-
Shares change
-
-621K
-
Total reported value, excl. options
-
$478K
-
Value change
-
-$674K
-
Number of buys
-
10
-
Number of sells
-
-8
-
Price
-
$0.87
Significant Holders of GeoVax Labs, Inc. - Common stock, par value $0.001 per share (GOVX) as of Q2 2025
23 filings reported holding GOVX - GeoVax Labs, Inc. - Common stock, par value $0.001 per share as of Q2 2025.
GeoVax Labs, Inc. - Common stock, par value $0.001 per share (GOVX) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 552K shares
of 28M outstanding shares and own 1.98% of the company stock.
Largest 10 shareholders include UBS Group AG (200K shares), VANGUARD GROUP INC (115K shares), GEODE CAPITAL MANAGEMENT, LLC (107K shares), MORGAN STANLEY (50.1K shares), BlackRock, Inc. (27.6K shares), STATE STREET CORP (16.8K shares), NORTHERN TRUST CORP (11.7K shares), MONETA GROUP INVESTMENT ADVISORS LLC (10K shares), CITIGROUP INC (4.1K shares), and SBI Securities Co., Ltd. (3.51K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.